Skip to main content
Clinical Trials/NCT01644214
NCT01644214UnknownNot Applicable

Extended Pessary Interval for Care (EPIC Study): Patient Preference for 3 Verus 6 Month Follow-up

Unity Health Toronto1 site in 1 country13 target enrollmentStarted: November 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
13
Locations
1
Primary Endpoint
Patient satisfaction

Study Overview

Brief Summary

Objectives: Pelvic organ prolapse (POP) is a common condition for which pessaries are commonly used in conservative treatment. Despite their prevalence, there is no literature to guide the management of pessaries. Our objective is to determine whether patients managed with a pessary for POP are more satisfied with follow-up at 3 or 6 month intervals and if there is any difference in complications rates between the two groups.

Hypothesis: The investigators hypothesize that there will be higher patient satisfaction in the group randomized to 6 month follow-up intervals and that there will be no difference in complication rates between the two follow-up groups.

Method: The investigators will conduct a prospective randomized control trial comparing patient satisfaction and complication rates between patients with pessaries randomized to either 3 or 6 month follow-up intervals over 1 year.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Females with POP who have opted for conservative management with a pessary
  • •Able to read and write English
  • •First time pessary users
  • •Successful fitting with a covered ring or Gellhorn pessary, as determined at the usual early follow-up visit 2-4 weeks after initial fitting (successful defined as: no expulsion on movement, squatting or valsalva, no urinary retention, no discomfort, and still retained pessary after 2 weeks)
  • •Patients agree to use vaginal estrogen (either tablet or cream twice weekly) during the study period; patients may not use a vaginal estrogen ring since this requires changing every 3 months, and will interfere with the study follow-up schedule

Exclusion Criteria

  • •Current presence of vaginal bleeding, vaginal abrasions or ulcers, or vaginal infection
  • •Significant cognitive impairment
  • •Pessary used for indication other than POP (ie. urinary incontinence)
  • •Use of a pessary that is not a covered ring or Gellhorn (i.e exclude cube, donut, etc.)
  • •Contraindications to vaginal estrogen
  • •Unsuccessful pessary fitting (successful defined as: no expulsion on movement, squatting or valsalva, no urinary retention, no discomfort, and still retained pessary after 2 weeks)

Arms & Interventions

Pessary Check at 3 months

No Intervention

Patients seen at 3 month intervals for pessary check-ups is the most common interval check in our clinic so this arm is considered the control group.

6 month Pessary Check

Experimental

Those that will be seen at 6 month follow-up visits for pessary maintenance will be considered the experimental group of the study.

Intervention: 6 month follow up for pessary check in the clinic setting (Other)

Outcomes

Primary Outcomes

Patient satisfaction

Time Frame: At 12 months from study enrollment

To determine if patients managed with a pessary for POP are more satisfied with follow-up at 6 or 12 weeks over a one year period.

Patient satisfaction

Time Frame: At 6 months from study enrollment

To determine if patients managed with a pessary for POP are more satisfied with follow-up at 6 or 12 weeks over a one year period.

Secondary Outcomes

  • Pessary associated complications(Checked at all follow-up visits (3 and 6 months, depending on study group))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials